Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism.

Psychiatric genetics - 1 Mar 2001

Løvlie R, Berle J O, Stordal E, Steen V M

Abstract excerpt

Twin, family and adoption studies have indicated that genetic susceptibility plays an important role in the etiology of bipolar disorder. Turecki et al. (1998) recently published preliminary evidence suggesting that bipolar patients with an excellent response to lithium treatment have a higher frequency of a specific dinucleotide repeat allele in the phospholipase Cgamma-1 (PLCG1) genomic region. The present work...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Dinucleotide Repeats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoenzymes

Share to Lithium

Share to Norway

Share to Phospholipase C gamma

Share to Type C Phospholipases

Share to White People

Source

Identifiers

PMID: 11409699
DOI: 10.1097/00041444-200103000-00008

Genes

PLCG1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism.PMID 11409699Read ↗

Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder.Semantic proximity Read ↗

Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder.Semantic proximity Read ↗

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.Semantic proximity Read ↗

Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.Semantic proximity Read ↗

[Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].Semantic proximity Read ↗

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.Semantic proximity Read ↗

Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.Semantic proximity Read ↗

Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.Semantic proximity Read ↗

Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.Semantic proximity Read ↗

Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder.Semantic proximity Read ↗

A study of genetic association between manic-depressive illness and a highly polymorphic marker from the GABRbeta-1 gene.Semantic proximity Read ↗

A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.